Bio Spectrum - February 2022
Bio Spectrum - February 2022
انطلق بلا حدود مع Magzter GOLD
اقرأ Bio Spectrum بالإضافة إلى 8,500+ المجلات والصحف الأخرى باشتراك واحد فقط عرض الكتالوج
1 شهر $9.99
1 سنة$99.99 $49.99
$4/ شهر
اشترك فقط في Bio Spectrum
سنة واحدة$11.88 $7.99
شراء هذه القضية $0.99
في هذه القضية
DRUG WAR INTENSIFIES
The pandemic has entered yet another phase, with the Omicron variant wreaking havoc across the globe. The high infection rate of this new cause for concern, in India, has also triggered a ‘war of medical opinions’ between the Indian Council of Medical Research (ICMR) and the Drugs Controller General of India (DCGI). Pharma majors are churning out viable treatment options at a feverish pace, in a bid to become the most widely accepted drug listed in COVID-19 treatment protocols. Merck’s Molnupiravir is one such drug that is embroiled in a ‘safety vs efficacy’ contest. Let’s investigate further
Bio Spectrum Magazine Description:
الناشر: MM Activ Sci-Tech Communication
فئة: Business
لغة: English
تكرار: Monthly
India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.
- إلغاء في أي وقت [ لا التزامات ]
- رقمي فقط